MediciNova Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,003.30
-
-
-
-
25.90
Cost of Goods Sold (COGS) incl. D&A
100.50
40.20
26.70
14.10
28.10
25.90
Gross Income
5,902.80
40.20
26.70
14.10
28.10
25.90
SG&A Expense
9,923.30
9,182.80
8,795.70
10,867.70
12,999.00
15,560.90
EBIT
4,020.50
9,223.00
8,822.40
10,881.80
13,027.10
15,586.80
Non Operating Income/Expense
4.00
23.80
15.30
19.60
119.90
22.90
Pretax Income
4,024.50
9,199.30
8,837.70
10,862.20
12,907.20
14,669.80
Income Tax
4.00
4.00
7.40
3.80
1,744.10
5.30
Consolidated Net Income
4,028.50
9,195.30
8,845.10
10,866.00
11,163.10
14,675.10
Net Income
4,028.50
9,195.30
8,845.10
10,866.00
11,163.10
14,675.10
Net Income After Extraordinaries
4,028.50
9,195.30
8,845.10
10,866.00
11,163.10
14,675.10
Net Income Available to Common
4,028.50
9,195.30
8,845.10
10,866.00
11,163.10
14,675.10
EPS (Basic)
0.19
0.38
0.33
0.33
0.32
0.36
Basic Shares Outstanding
20,697.40
24,067.80
26,578.80
32,986.70
35,137.00
41,124.90
EPS (Diluted)
0.19
0.38
0.24
0.33
0.32
0.36
Diluted Shares Outstanding
20,697.40
24,067.80
36,319.10
32,986.70
35,137.00
41,124.90
EBITDA
3,920.10
9,182.80
8,795.70
10,867.70
12,999.00
15,561

About MediciNova

View Profile
Address
4275 Executive Square
La Jolla California 92037
United States
Employees -
Website http://www.medicinova.com
Updated 07/08/2019
MediciNova, Inc. is a biopharmaceutical company, which engages in acquiring and developing novel, small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need. The firm's development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.